Cytoplasmic ribonuclease inhibitor.
Shapiro
R
R
Center for Biochemical and Biophysical Sciences and Medicine, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
D000818:Animals; D003593:Cytoplasm / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000302:isolation & purification* / Q000494:pharmacology; D004926:Escherichia coli / Q000201:enzymology; D005260:Female; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D007700:Kinetics; D008322:Mammals; D008958:Models, Molecular; D010926:Placental Hormones / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D011247:Pregnancy; D011487:Protein Conformation; D011506:Proteins / Q000737:chemistry / Q000494:pharmacology; D051381:Rats; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000494:pharmacology; D012259:Ribonuclease, Pancreatic / Q000037:antagonists & inhibitors / Q000737:chemistry; D012260:Ribonucleases / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D010926:Placental Hormones; D011506:Proteins; D011994:Recombinant Proteins; C022052:placental ribonuclease inhibitor; C066953:ribonuclease inhibitor, porcine; D012260:Ribonucleases; C046366:angiogenin; D012259:Ribonuclease, Pancreatic